Two of our patients experienced myotoxicity associated with colchicine administration. The
first was a 54‐year‐old woman who was receiving dialysis and came to the emergency …

Colchicine has been in use for therapeutic purposes for many years. It can, however, cause
subacute onset muscle and peri phe ral nerve toxicity in patients with chronic renal failure. In …

Colchicine is derived from the corms of Colchicum autumnale and has been artificially
synthesised for the treatment of gout. Although the drug has been used therapeutically for …

Although colchicine has been used for centuries, its neuromuscular toxicity in humans is
largely unrecognized. In this report we describe a characteristic syndrome of myopathy and …

Colchicine is an approved agent in the management and prophylaxis of gout and familial
Mediterranean fever but its therapeutic value is limited by its narrow therapeutic index …

Introduction. Therapeutic doses of colchicine in patients with renal compromise and
cyclosporine therapy may result in increased plasma concentrations of colchicine and …

OBJECTIVE: To report a case of rhabdomyolysis occurring during treatment with colchicine.
CASE SUMMARY: A 44-year-old African American man was admitted to the hospital due to …

Colchicine may produce a neuromuscular disorder even when given in customary doses.
We report the electrodiagnostic features in eight pathologically proven cases of colchicine …

The therapeutic virtues of colchicine have been known since the 6th century AD, and it has
been used since the 19th century for the treatment of gouty arthritis (for historical review see …

Colchicine causes both muscle and peripheral nerve toxicity of subacute onset in patients
with renal insufficiency. We report three cardiac transplant recipients, treated with colchicine …